AlphaFold predicted structure
ACY1 · Q03154

Mean pLDDT
96.4/ 100
Very high
408 residues
Confidence breakdown
- Very high(≥ 90)97%
- Confident(70–90)2%
- Low(50–70)1%
- Very low(< 50)1%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
aminoacylase 1
Annotations refreshed 10 hours ago.
Diagnostic Grade (Green)
DDG2P
BIALLELIC, autosomal or pseudoautosomalFetal anomalies
BIALLELIC, autosomal or pseudoautosomalIntellectual disability
BIALLELIC, autosomal or pseudoautosomalLikely inborn error of metabolism
BIALLELIC, autosomal or pseudoautosomalUndiagnosed metabolic disorders
BIALLELIC, autosomal or pseudoautosomalChildhood onset dystonia, chorea or related movement disorder
aminoacylase 1 deficiency
Neurological conditions associated with aminoacylase 1 deficiency
Intellectual disability
hereditary disease
toxic encephalopathy
inborn aminoacylase deficiency
neurodegenerative disease
neuroblastoma
colorectal carcinoma
non-small cell lung carcinoma
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Aminoacylase-1
Aminoacylase involved in the hydrolysis of N-acetylated and N-formylated amino acids. May act sequentially with APEH in the degradation of N-acylated peptides: APEH first cleaves N-acylaminoacids from N-acylated peptides, then ACY1 further hydrolyzes the N-acylaminoacid into free aminoacid and a carboxylate
ACY1 · Q03154

Mean pLDDT
96.4/ 100
Very high
408 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0